Ofloxacin, Ornidazole, Itraconazole & Clobetasol Propionate cream – GYREX C

Ofloxacin, Ornidazole, Itraconazole & Clobetasol Propionate cream – Action for Resistant Fungal, Bacterial & Inflammatory Skin Infections.

GYREX C: Ofloxacin 0.75% + Ornidazole 2.00% + Itraconazole 1.00% + Clobetasol Propionate 0.05% + Methyl Paraben 0.20% Cream formulation delivers comprehensive management of polymicrobial and inflammatory skin infections. Ofloxacin inhibits bacterial DNA replication, Ornidazole targets anaerobic bacteria and protozoa, Itraconazole disrupts fungal cell membrane synthesis, and Clobetasol mitigates inflammation. Ideal for use in dermatological infections with suspected fungal, bacterial, and inflammatory etiology.

Recommended By Specialists>
 Dermatologists – It is preferred to treat the disease associated with mixed bacterial, fungal, and protozoal skin infections with inflammation.
 General Physicians –It is preferred to treat the disease associated with polymicrobial skin infections requiring broad-spectrum coverage.

Key Benefits of Ofloxacin, Ornidazole, Itraconazole & Clobetasol Propionate cream – GYREX C:
Broad-Spectrum Antimicrobial Coverage – Combines Ofloxacin and Ornidazole to treat aerobic, anaerobic, and protozoal infections in mixed skin conditions.
 Potent Antifungal with Itraconazole – Itraconazole effectively targets resistant dermatophytes and yeast infections, making it ideal for chronic fungal dermatoses.
 Steroidal Anti-Inflammatory Relief – Clobetasol offers high-potency corticosteroid action to reduce redness, itching, and swelling in inflammatory and infected skin lesions.

INDICATIONS:
 Fungal Dermatoses with Secondary Infection
 Mixed Bacterial-Fungal Skin Infections
 Inflammatory Tinea Infections
 Infected Eczema or Psoriasis